CorMedix News

Cormedix Analyst Ratings

BenzingaMay 13 05:31 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Beam Therapeutics (BEAM), Cormedix (CRMD) and Applied Therapeutics (APLT)

TipRanksMay 10 21:50 ET

Analysts' Top Healthcare Picks: Cormedix (CRMD), SCYNEXIS (SCYX)

TipRanksMay 10 12:10 ET

Truist Financial Reaffirms Their Buy Rating on Cormedix (CRMD)

TipRanksMay 10 08:09 ET

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Evolent Health (EVH) and Cormedix (CRMD)

TipRanksMay 10 01:10 ET

Truist Financial Remains a Buy on Cormedix (CRMD)

TipRanksApr 9 07:35 ET

Cormedix Analyst Ratings

BenzingaApr 9 06:06 ET

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Shandong Weigao Group Medical Polymer Co (OtherSHWGF) and Cormedix (CRMD)

TipRanksApr 9 00:30 ET

Cormedix Analyst Ratings

BenzingaMar 13 10:55 ET

RBC Capital Remains a Buy on Cormedix (CRMD)

TipRanksMar 13 06:40 ET

Analysts Offer Insights on Healthcare Companies: Cencora (COR), Cormedix (CRMD) and NeueHealth Inc (NEUE)

TipRanksMar 13 06:41 ET

Cormedix Analyst Ratings

BenzingaMar 12 16:34 ET

Buy Rating on Cormedix Amidst DefenCath Launch and Strong Financial Positioning

TipRanksMar 12 15:35 ET

Analysts Are Bullish on These Healthcare Stocks: Cormedix (CRMD), PROCEPT BioRobotics (PRCT)

TipRanksMar 12 12:20 ET

Cormedix Analyst Ratings

BenzingaJan 31 13:42 ET

Buy Rating Affirmed: Cormedix's DefenCath Poised for Success With Positive Reimbursement Outlook and Strategic Launch Plan

TipRanksJan 30 12:45 ET

RBC Capital Maintains Outperform on Cormedix, Raises Price Target to $10

BenzingaNov 15, 2023 13:47 ET

JMP Securities Reiterates Market Outperform on Cormedix, Maintains $19 Price Target

BenzingaNov 15, 2023 12:57 ET

Cormedix Analyst Ratings

BenzingaNov 15, 2023 12:55 ET

RBC Boosts Price Target on CorMedix to $10 From $6 on 'Heightening Prospects of DefenCath Reaching Market,' Keeps Outperform, Speculative Risk

MT NewswiresNov 15, 2023 07:54 ET